On the other hand, Itamochi H et al. reported that the use of CHK inhibitors could improve the drug resistance of OCCC to cisplatin [16], while the main function of cell cycle checkpoint kinase (CHK) was to regulate the synthesis of DNA in tumor cells. The gene discussed is CHEK1; the disease is neoplasm.